ArticleACS chemical biology2016

Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.

Eduardo Henrique Silva Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.